SecSonar.com

Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Organogenesis Holdings Inc. (ORGO) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $331.3M. Revenue grew 16.8% year-over-year and free cash flow was negative at -$24.5M. This page tracks ORGO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 869 employees · IPO Jan 5, 2017

Valuation

Valuation & price

$2.41 · as of May 17, 2026 · -63.1% vs 52w high

8.5

P/E ratio

Latest-FY diluted EPS

0.76

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.54$4.39$2.24Jul 25Dec 25Jul 26Jul 7, 25$4.25Jul 9, 25$4.46Jul 11, 25$4.30Jul 15, 25$4.03Jul 17, 25$4.36Jul 21, 25$4.56Jul 23, 25$4.98Jul 25, 25$5.03Jul 29, 25$4.77Jul 31, 25$4.62Aug 4, 25$4.60Aug 6, 25$4.50Aug 11, 25$4.61Aug 13, 25$4.91Aug 15, 25$4.73Aug 19, 25$4.48Aug 21, 25$4.47Aug 25, 25$4.67Aug 27, 25$4.84Aug 29, 25$5.15Sep 3, 25$4.96Sep 5, 25$5.00Sep 9, 25$4.89Sep 11, 25$5.04Sep 16, 25$4.86Sep 18, 25$4.75Sep 22, 25$4.72Sep 24, 25$4.90Sep 26, 25$4.10Sep 30, 25$4.22Oct 2, 25$4.23Oct 6, 25$4.20Oct 8, 25$4.13Oct 10, 25$3.96Oct 14, 25$4.00Oct 16, 25$4.06Oct 21, 25$4.07Oct 23, 25$4.11Oct 27, 25$4.28Oct 29, 25$4.17Oct 31, 25$4.25Nov 4, 25$3.88Nov 6, 25$3.89Nov 10, 25$6.54Nov 12, 25$6.48Nov 14, 25$6.10Nov 18, 25$5.52Nov 20, 25$5.12Nov 25, 25$5.28Nov 28, 25$5.18Dec 2, 25$5.02Dec 4, 25$4.92Dec 8, 25$4.66Dec 10, 25$4.73Dec 12, 25$4.82Dec 16, 25$5.17Dec 18, 25$5.77Dec 22, 25$5.71Dec 24, 25$5.87Dec 29, 25$5.21Jan 2, 26$4.64Jan 6, 26$4.36Jan 8, 26$4.21Jan 12, 26$4.23Jan 14, 26$3.87Jan 16, 26$3.79Jan 21, 26$3.84Jan 23, 26$3.92Jan 27, 26$3.99Jan 29, 26$4.01Feb 2, 26$4.23Feb 4, 26$3.90Feb 9, 26$3.83Feb 11, 26$3.76Feb 13, 26$3.73Feb 18, 26$3.84Feb 20, 26$3.99Feb 24, 26$4.03Feb 26, 26$3.70Mar 2, 26$3.00Mar 4, 26$2.87Mar 6, 26$2.79Mar 10, 26$2.71Mar 12, 26$2.65Mar 17, 26$2.53Mar 19, 26$2.40Mar 23, 26$2.47Mar 25, 26$2.44Mar 27, 26$2.29Mar 31, 26$2.37Apr 2, 26$2.24Apr 7, 26$2.26Apr 9, 26$2.29Apr 13, 26$2.38Apr 15, 26$2.60Apr 17, 26$2.50Apr 22, 26$2.41Apr 24, 26$2.35Apr 28, 26$2.40Apr 30, 26$2.35May 4, 26$2.56May 6, 26$2.56May 8, 26$2.37May 12, 26$2.41May 14, 26$2.59May 18, 26$2.48May 20, 26$2.55May 22, 26$2.66May 28, 26$2.62Jun 1, 26$2.36Jun 3, 26$2.33Jun 5, 26$2.42Jun 9, 26$2.48Jun 11, 26$2.38Jun 15, 26$2.41Jun 17, 26$2.34Jun 22, 26$2.43Jun 24, 26$2.44Jun 26, 26$2.43Jul 2, 26$2.36
$2.2452-week range$6.54
Loading valuation history…

Fundamentals

Key fundamentals

$331.3M

Market cap

16.8%

Revenue growth (YoY)

75.6%

Gross margin

-$24.5M

Free cash flow (USD)

$39.2M

Net debt

-3.8%

Share dilution

4/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$193.4MFY 2019$261.0MFY 2020$338.3MFY 2021$467.4MFY 2022$450.9MFY 2023$433.1MFY 2024$482.0MFY 2025$563.0M
$0$563M

Free cash flow by year

2016 → 2025

FY 2016$-1.9MFY 2017$-3.0MFY 2018$-62.6MFY 2019$-39.8MFY 2020$-12.2MFY 2021$30.8MFY 2022$-9.0MFY 2023$6.6MFY 2024$4.2MFY 2025$-24.5M
-$1.9M-$24.5M

Gross margin by year

2021 → 2025

FY 202175.6%FY 202276.7%FY 202375.4%FY 202476.0%FY 202575.6%
75.6%75.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDirector ElectionJun 16, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is Organogenesis Holdings Inc.'s market cap?

Organogenesis Holdings Inc. (ORGO) has a market capitalization of $331.3M.

What is ORGO's P/E ratio?

ORGO trades at a price-to-earnings ratio of 8.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ORGO's price-to-book (P/B) ratio?

ORGO trades at 0.76 times book value per share.

Are insiders buying ORGO stock?

SEC Form 4 filings show no open-market insider buys at Organogenesis Holdings Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

SIGA

SIGA Technologies, Inc.

$340.3M

SNDL

SNDL Inc.

$383.8M

TKNO

Alpha Teknova, Inc.

$270.2M

AQST

Aquestive Therapeutics, Inc.

$404.7M

EOLS

Evolus, Inc.

$434.3M

KMDA

Kamada Ltd.

$451.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.